QuidelOrtho Operating Margin 2010-2025 | QDEL
Current and historical operating margin for QuidelOrtho (QDEL) over the last 10 years. The current operating profit margin for QuidelOrtho as of March 31, 2025 is 5.77%.
| QuidelOrtho Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $2.77B | $-0.17B | -6.15% |
| 2024-12-31 | $2.78B | $-1.96B | -70.46% |
| 2024-09-30 | $2.82B | $-1.82B | -64.62% |
| 2024-06-30 | $2.84B | $-1.81B | -63.84% |
| 2024-03-31 | $2.86B | $-1.72B | -60.04% |
| 2023-12-31 | $3.00B | $0.14B | 4.64% |
| 2023-09-30 | $3.12B | $0.19B | 5.93% |
| 2023-06-30 | $3.16B | $0.22B | 6.83% |
| 2023-03-31 | $3.11B | $0.32B | 10.39% |
| 2022-12-31 | $3.27B | $0.84B | 25.85% |
| 2022-09-30 | $3.04B | $1.14B | 37.38% |
| 2022-06-30 | $2.76B | $1.36B | 49.24% |
| 2022-03-31 | $2.33B | $1.30B | 56.02% |
| 2021-12-31 | $1.70B | $0.91B | 53.33% |
| 2021-09-30 | $1.87B | $1.15B | 61.25% |
| 2021-06-30 | $1.84B | $1.17B | 63.80% |
| 2021-03-31 | $1.86B | $1.23B | 66.22% |
| 2020-12-31 | $1.66B | $1.06B | 63.84% |
| 2020-09-30 | $1.01B | $0.48B | 47.66% |
| 2020-06-30 | $0.66B | $0.19B | 29.31% |
| 2020-03-31 | $0.56B | $0.11B | 20.32% |
| 2019-12-31 | $0.53B | $0.09B | 17.42% |
| 2019-09-30 | $0.52B | $0.09B | 16.70% |
| 2019-06-30 | $0.51B | $0.08B | 16.21% |
| 2019-03-31 | $0.50B | $0.08B | 15.17% |
| 2018-12-31 | $0.52B | $0.10B | 18.39% |
| 2018-09-30 | $0.50B | $0.07B | 14.29% |
| 2018-06-30 | $0.44B | $0.05B | 11.87% |
| 2018-03-31 | $0.37B | $0.04B | 10.99% |
| 2017-12-31 | $0.28B | $0.01B | 3.24% |
| 2017-09-30 | $0.22B | $0.01B | 5.09% |
| 2017-06-30 | $0.21B | $0.02B | 7.48% |
| 2017-03-31 | $0.22B | $0.02B | 8.37% |
| 2016-12-31 | $0.19B | $0.00B | -2.09% |
| 2016-09-30 | $0.19B | $-0.01B | -3.68% |
| 2016-06-30 | $0.19B | $-0.01B | -4.26% |
| 2016-03-31 | $0.18B | $-0.01B | -4.89% |
| 2015-12-31 | $0.20B | $0.00B | 1.53% |
| 2015-09-30 | $0.21B | $0.01B | 6.22% |
| 2015-06-30 | $0.20B | $0.00B | 0.99% |
| 2015-03-31 | $0.20B | $0.00B | 1.01% |
| 2014-12-31 | $0.18B | $-0.01B | -4.89% |
| 2014-09-30 | $0.17B | $-0.02B | -12.87% |
| 2014-06-30 | $0.16B | $-0.02B | -10.98% |
| 2014-03-31 | $0.16B | $-0.02B | -9.20% |
| 2013-12-31 | $0.18B | $0.00B | 2.25% |
| 2013-09-30 | $0.18B | $0.02B | 10.56% |
| 2013-06-30 | $0.18B | $0.02B | 13.41% |
| 2013-03-31 | $0.18B | $0.03B | 14.44% |
| 2012-12-31 | $0.16B | $0.01B | 5.77% |
| 2012-09-30 | $0.14B | $0.00B | -2.86% |
| 2012-06-30 | $0.14B | $0.00B | -2.86% |
| 2012-03-31 | $0.14B | $0.00B | -2.92% |
| 2011-12-31 | $0.16B | $0.01B | 8.81% |
| 2011-09-30 | $0.15B | $0.01B | 7.19% |
| 2011-06-30 | $0.15B | $0.01B | 6.08% |
| 2011-03-31 | $0.15B | $0.01B | 4.14% |
| 2010-12-31 | $0.11B | $-0.02B | -14.16% |
| 2010-09-30 | $0.15B | $0.02B | 11.49% |
| 2010-06-30 | $0.18B | $0.04B | 25.00% |
| 2010-03-31 | $0.18B | $0.05B | 30.11% |
| 2009-12-31 | $0.17B | $0.05B | 31.52% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.761B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.305B | 26.89 |
| Boston Scientific (BSX) | United States | $152.872B | 36.46 |
| Stryker (SYK) | United States | $146.007B | 29.72 |
| EssilorLuxottica (ESLOY) | France | $145.127B | 0.00 |
| Medtronic (MDT) | Ireland | $119.233B | 16.91 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.313B | 24.74 |
| ResMed (RMD) | United States | $41.712B | 29.83 |
| Agilent Technologies (A) | United States | $33.861B | 22.07 |
| GE HealthCare Technologies (GEHC) | United States | $33.512B | 15.75 |
| Terumo (TRUMY) | Japan | $27.642B | 32.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.451B | 17.50 |
| Insulet (PODD) | United States | $22.615B | 75.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.354B | 12.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.855B | 0.00 |
| Baxter (BAX) | United States | $12.419B | 9.60 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.731B | 28.40 |
| Lantheus Holdings (LNTH) | United States | $3.684B | 9.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.430B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.198B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.123B | 7.80 |
| ICU Medical (ICUI) | United States | $2.986B | 20.33 |
| Haemonetics (HAE) | United States | $2.589B | 11.56 |
| LeMaitre Vascular (LMAT) | United States | $2.171B | 46.56 |
| Curaleaf Holdings (CURLF) | Canada | $1.782B | 0.00 |
| AtriCure (ATRC) | United States | $1.762B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.601B | 68.73 |
| AdaptHealth (AHCO) | United States | $1.283B | 18.24 |
| Phibro Animal Health (PAHC) | United States | $1.243B | 15.89 |
| Acuren (TIC) | United States | $1.190B | 0.00 |
| Neogen (NEOG) | United States | $1.179B | 18.72 |
| BioLife Solutions (BLFS) | United States | $1.166B | 2434.00 |
| Tilray Brands (TLRY) | Canada | $1.134B | 0.00 |
| Valneva SE (VALN) | France | $0.981B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 8.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.824B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.665B | 0.00 |
| Surmodics (SRDX) | United States | $0.536B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.482B | 0.00 |
| CeriBell (CBLL) | United States | $0.451B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.451B | 15.53 |
| Owens & Minor (OMI) | United States | $0.439B | 3.89 |
| Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
| Evolus (EOLS) | United States | $0.435B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.364B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.312B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.287B | 0.00 |
| Omeros (OMER) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.254B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 49.92 |
| Cerus (CERS) | United States | $0.238B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.212B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
| Biote (BTMD) | United States | $0.144B | 4.79 |
| Jushi Holdings (JUSHF) | United States | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.08 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.12 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.05 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.029B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |